20/20 Biolabs, Inc. (AIDX) › Cash & Equivalents20/20 Biolabs, Inc. (AIDX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $1.78M2025: $1.03M$1.03M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.03M-42.5%2024$1.78M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share